Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi(TM) (DFD-29) to Treat Rosacea
Stock Information for Amarin Corporation plc
Loading
Please wait while we load your information from QuoteMedia.